Topics
- Alignment of pre-clinical models with optimised clinical strategies - a translational strategy
- Effective approaches to overcome regulatory challenges for early phase trial approval in China, India and Korea
- Optimization of trial design to effectively meet early phase study timelines
- Mitigation of risks and costs by designing a streamlined safety early phase study
- Effective modelling and simulation tools
- Outsourcing of strategies and partnership selection and maintenance with CROs
- Early phase trial with low availability of patients
Who should Attend
Directors, Heads and Managers of: Clinical Operations, Clinical Research, Clinical Pharmacology, Clinical Development, Clinical Project Managers, Medical Directors, Regulatory Affairs, Translational Medicine, Biomarker Development, Principle investigators and Clinical study design.
